Wall Street brokerages predict that Sharps Compliance Corp. (NASDAQ:SMED – Get Rating) will report earnings of $0.04 per share for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Sharps Compliance’s earnings. The highest EPS estimate is $0.05 and the lowest is $0.02. Sharps Compliance reported earnings of $0.40 per share in the same quarter last year, which indicates a negative year-over-year growth rate of 90%. The business is scheduled to report its next quarterly earnings report before the market opens on Monday, January 1st.
According to Zacks, analysts expect that Sharps Compliance will report full year earnings of $0.12 per share for the current financial year, with EPS estimates ranging from $0.09 to $0.14. For the next financial year, analysts expect that the firm will post earnings of $0.16 per share, with EPS estimates ranging from $0.13 to $0.19. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that follow Sharps Compliance.
Sharps Compliance (NASDAQ:SMED – Get Rating) last posted its quarterly earnings results on Wednesday, January 26th. The industrial products company reported $0.07 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.08 by ($0.01). Sharps Compliance had a net margin of 15.91% and a return on equity of 19.50%. The firm had revenue of $18.88 million for the quarter, compared to analysts’ expectations of $18.41 million. During the same period last year, the firm posted $0.07 EPS.
Several large investors have recently added to or reduced their stakes in the stock. Royce & Associates LP lifted its stake in shares of Sharps Compliance by 4.6% in the fourth quarter. Royce & Associates LP now owns 1,197,572 shares of the industrial products company’s stock worth $8,539,000 after acquiring an additional 52,579 shares in the last quarter. BlackRock Inc. lifted its stake in shares of Sharps Compliance by 3.5% in the fourth quarter. BlackRock Inc. now owns 842,782 shares of the industrial products company’s stock worth $6,010,000 after acquiring an additional 28,676 shares in the last quarter. Granahan Investment Management Inc. MA lifted its stake in shares of Sharps Compliance by 5.9% in the third quarter. Granahan Investment Management Inc. MA now owns 751,054 shares of the industrial products company’s stock worth $6,211,000 after acquiring an additional 41,897 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Sharps Compliance by 35.4% in the fourth quarter. Goldman Sachs Group Inc. now owns 666,777 shares of the industrial products company’s stock worth $4,754,000 after acquiring an additional 174,370 shares in the last quarter. Finally, Morgan Stanley lifted its stake in shares of Sharps Compliance by 244.7% in the second quarter. Morgan Stanley now owns 603,414 shares of the industrial products company’s stock worth $6,215,000 after acquiring an additional 428,350 shares in the last quarter. Institutional investors and hedge funds own 54.72% of the company’s stock.
SMED stock opened at $4.32 on Thursday. The stock has a 50-day moving average price of $5.44 and a two-hundred day moving average price of $6.62. Sharps Compliance has a 12-month low of $4.25 and a 12-month high of $18.15. The company has a current ratio of 3.85, a quick ratio of 3.40 and a debt-to-equity ratio of 0.06. The company has a market cap of $83.16 million, a PE ratio of 6.00 and a beta of -0.22.
Sharps Compliance Company Profile (Get Rating)
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications.
- Get a free copy of the StockNews.com research report on Sharps Compliance (SMED)
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- Iridium Communications Stock is Ready to Return to Orbit
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.